Titre : | Nine reasons why ecstasy is not quite what it used to be (2018) |
Auteurs : | J. MOUNTENEY ; P. GRIFFITHS ; A. BO ; A. CUNNINGHAM ; J. MATIAS ; A. PIRONA |
Type de document : | Article : Périodique |
Dans : | International Journal of Drug Policy (Vol.51, January 2018) |
Article en page(s) : | 36-41 |
Langues: | Anglais |
Discipline : | MAR (Marchés / Markets) |
Mots-clés : |
Thésaurus géographique EUROPEThésaurus mots-clés MDMA-ECSTASY ; MARCHE DE LA DROGUE ; PRECURSEURS ; ADULTERANT ; INTERNET |
Résumé : | This paper explores the recent resurgence in use of ecstasy/MDMA in Europe and highlights keys areas of continuity and divergence between the ecstasy market of the 1990s and the current MDMA market. Based on a scoping study involving a targeted multi-source data collection exercise on MDMA, it highlights nine areas that have undergone some level of change, linked with both supply and demand for the drug. Factors discussed include: innovation in production techniques; changes in precursor chemical availability; the role of online markets; competition with other stimulants and new psychoactive substances; the increased availability of high-strength MDMA; and the shift from subcultural towards more mainstream use of the drug. The paper proposes that the MDMA on Europe’s contemporary market is in some respects a third generation product with a different consumer profile, with implications that responses developed at the time of the drug’s earlier iteration, may be in need of a review and revamp. |
Domaine : | Drogues illicites / Illicit drugs |
Affiliation : | European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Lisbon, Portugal |
Cote : | Abonnement |
Accueil